Objective: To assess the efficacy of commercial intra-articular blood-derived allogeneic-induced mesenchymal stem cells (CIMSCs) to treat tarsometatarsal lameness in horses.

Study Design: This was a retrospective cohort study.

Animals: Records from 167 adult light breed horses with bilateral tarsometatarsal lameness.

Methods: Horses with tarsometatarsal lameness were retrospectively selected from medical records. Diagnosis followed subjective graded lameness assessment before and after intra-articular analgesia, with graded radiographic tarsal examination. Horses were excluded if they were diagnosed or treated for any other concurrent lameness conditions during the study. Time to last follow-up and time of recurrence of lameness was recorded at veterinary re-assessment.

Results: A total of 67 horses were recruited to the CIMSC-treated group and 100 to the corticosteroid (CS)-treated group. Median age was 9 years, with no difference in signalment, use or radiographic grade between groups. First re-examination was 38 days (95% CI: 38-49), with no difference between groups, CIMSC 42 (35-45), control 34 (25-42). Median follow-up was 438 days for CIMSC, 546 for controls. Symptoms of lameness recurred in 86/100 controls compared to 17/67 (25%) CIMSC. Median time to lameness recurring in CIMSC was 336 days (95% CI: 239-400), control 90 days (95% CI: 80-108), p < .0001. Cox proportional hazard ratio for treatment was 8.35, 95% CI: 4.67 to 14.92, p < .0001.

Conclusions: Lameness was abolished in all treated horses. It recurred significantly less often, and later, in CIMSC-treated horses.

Clinical Significance: Intra-articular CIMSC treatment results in prolonged soundness in horses with tarsometatarsal lameness.

Download full-text PDF

Source
http://dx.doi.org/10.1111/vsu.14030DOI Listing

Publication Analysis

Top Keywords

tarsometatarsal lameness
12
mesenchymal stem
8
stem cells
8
lameness
8
horses
5
allogeneic chondrogenic-induced
4
chondrogenic-induced mesenchymal
4
cells treatment
4
tarsometatarsal
4
treatment tarsometatarsal
4

Similar Publications

Objective: To determine with mechanical nociceptive threshold (MNT) testing whether distal limb skin sensation is affected by intra-articular anesthesia of the tarsometatarsal joint (TMTJ).

Animals And Procedure: This was a prospective cohort study. Ten client-owned horses that had intra-articular TMTJ anesthesia were included in the study.

View Article and Find Full Text PDF

Treatment of Medial Instability of the Carpometacarpal and Tarsometatarsal Joints Using the Isolock System in Two Dogs.

Animals (Basel)

February 2024

Department of Veterinary Medical Sciences, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano dell'Emilia, Bologna, Italy.

This case report describes a novel procedure using the Isolock Intrauma implant system for treating medial instability of the carpometacarpal and tarsometatarsal joints, as demonstrated in in two dogs. A 9-year-old spayed female Spanish greyhound presented with a non-weight-bearing right hindlimb following a trauma. The clinical and radiological findings confirmed medial tarsometatarsal instability consistent with valgus deviation of the tarsus and the opening of the joint line on the medial aspect from the first to the third tarsometatarsal joints.

View Article and Find Full Text PDF

Limited evidence is available relating gait changes to diagnostic anaesthesia. We investigated associations between specific movement patterns and diagnostic anaesthesia of different anatomical structures in a retrospective analysis. Referral-level lameness cases were included with the following criteria: presence of diagnostic anaesthesia of a forelimb and/or hind limb; subjective efficacy classified as "negative", "partially positive", or "positive"; quantitative gait data available from inertial measurement units.

View Article and Find Full Text PDF

Objective: To raise awareness of the potential for intra-articular subchondral bone sequestrum formation secondary to a traumatic or septic process to enable more rapid identification of this uncommon but possible outcome in future cases.

Animal: A client-owned 12-year-old Appaloosa mare.

Clinical Presentation, Progression, And Procedures: The mare had a wound to the lateral aspect of the fourth metatarsal bone (MT4) that communicated with the distal tarsal joints.

View Article and Find Full Text PDF

Objective: To assess the efficacy of commercial intra-articular blood-derived allogeneic-induced mesenchymal stem cells (CIMSCs) to treat tarsometatarsal lameness in horses.

Study Design: This was a retrospective cohort study.

Animals: Records from 167 adult light breed horses with bilateral tarsometatarsal lameness.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!